BridgeBio Pharma, Inc. (BBIO) Gross margin 2021–2025
BridgeBio Pharma, Inc. (BBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
95.8%FY2025 · since FY2021: 95.5% → 95.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 95.8% | -2.4 pp |
| FY2024 | 98.3% | +24.5 pp |
| FY2023 | 73.7% | -21.9 pp |
| FY2022 | 95.6% | +0.0 pp |
| FY2021 | 95.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice